
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
TRANSDERMAL DRUG DELIVERY SILICONE ADHESIVE MARKET
A transdermal drug delivery system (TDDS) is an adhesive patch that contains a medicine or medication and is applied to the skin in order to transdermally administered predetermined doses to the body over time at a predetermined release rate.
For patients who use transdermal drug delivery systems, silicone adhesives offer stable adherence and painless removal. Adhesive skin patches deliver medication to the body painlessly and gradually without causing any harm. They are simple to use, do not involve the administration of any injections or pills, and have fewer adverse effects.
The Global Transdermal Drug Delivery silicone adhesive market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
New silicone materials were developed with a focus on their role as excipients influencing drug delivery in topical and transdermal systems.
Recent innovations including swelling crosslinked silicone elastomer mix networks, sugar siloxanes, amphiphilic resin linear polymers, and silicone hybrid pressure sensitive adhesives promise possible performance benefits and increased drug delivery efficacy.
The physicochemical characteristics of the drug, the route of administration, the kind of delivery vehicle, the mechanism of drug release, the ability to target, and the product's biocompatibility must all be taken into account simultaneously when developing controlled release drug delivery systems.
This poses significant difficulties for creating a controlled release dosage form tailored to the administration method, such as oral or cutaneous medication delivery.
Excipients, or inert chemicals used to carry out various tasks in the product, are often present in topical/transdermal formulations at a rate of 90% or more.
The composition of the formulation, which may change the characteristics of the skin and consequently influence the permeation of the medication, as well as the physiochemical nature of the drug also play a role in the penetration and permeation of the drug through the skin.
Polymeric substances can affect drug distribution but also serve as the base or matrix for the final dose form in topical preparations.
Individual polymers or polymer mixtures have historically been used to regulate drug release qualities because different medicines interact with different polymers in different ways and have distinct effects on the release properties.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2023-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |